Menu
Pharmaceuticals
600
Ocular Therapeutix, a biopharmaceutical company, is revolutionizing the field of ophthalmology with its innovative drug formulations. By leveraging its proprietary bioresorbable hydrogel-based technology, the company aims to develop sustained-release therapies that simplify the current standard of care and improve patient outcomes. With a robust product pipeline, Ocular Therapeutix is focused on advancing its therapies through clinical trials and commercialization. The company’s first commercial drug, DEXTENZA®, has already gained FDA approval and is making a significant impact in the treatment of ocular inflammation and pain. Today the company is fostering a partnership mindset to maximize the value of its pipeline and unlock new collaborations. With a target market opportunity of $12 billion in the U.S., the company is on a trajectory of rapid growth.
As the company continued to revolutionize the standard of care with its sustained-release therapies and expanded its product pipeline across multiple therapeutic areas, it encountered several challenges related to in-house HR and identity provisioning processes. With a strong focus on developing groundbreaking products, the company needed robust protection for its intellectual property, technical know-how, and regulatory applications to safeguard exclusivity. Hence, ensuring smooth offboarding processes became crucial to prevent terminated employees from accessing sensitive data and systems. At the same time, growth is indispensable for the company, making efficient onboarding essential to drive collaboration and progress. However, the manual handling of employee lifecycle management tasks proved time-consuming, error-prone, and posed potential data breach risks.
The lack of integration between the HR system, ADP and AD (Active Directory) resulted in inconsistencies in employee profiles and delayed updates to roles and privileges. This disjointed approach not only hindered collaboration and productivity but also highlighted the pressing need for a comprehensive solution that would automate and streamline HR and identity provisioning processes, ensuring accuracy, efficiency, and compliance.
To address these challenges, Ocular Therapeutix turned to RoboMQ, a trusted provider of data and API integration solutions. RoboMQ offered the perfect solution with its Hire2Retire integration product, which seamlessly integrates HR processes with identity provisioning. By implementing Hire2Retire, Ocular Therapeutix achieved real-time synchronization of employee updates between ADP and the Active Directory. This resulted in significant benefits for the company, including:
Pharmaceuticals
600
MSI Chicago puts a fully automated “Hire to Retire’ business process in place to keep up with the seasonal…Know More
Hudson Headwaters Health Network enables better patient experience by building prompt & secure role-based access… Know More
